Trial Profile
A multicenter phase III randomized study of 153Sm-EDTMP and Docetaxel + Prednisone versus Docetaxel + Prednisone in Taxane-naive patients with metastatic hormone-refractory prostate cancer.
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 23 May 2014
Price :
$35
*
At a glance
- Drugs Samarium 153 lexidronam (Primary) ; Docetaxel; Prednisone
- Indications Prostate cancer
- Focus Therapeutic Use
- Acronyms SAMDOCET
- 06 Jul 2011 New trial record